Dissolved and financials
CVR: 40337326
DKK -736,481
Gross profit
Net result: DKK -1,363,690
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 17 May 2022
CVR · view overview
2 employees
CVR · 2020
Director role ended: Preben Meldgaard
CVR · 17/05/2022
View the full event history
Betamab ApS was a Danish company of the type Anpartsselskab based in Humlebæk, founded in 2019. The company has been dissolved on 17 May 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 2 employees (2020). In 2020, the company reported a gross profit of DKK -736,481 and a net result of DKK -1,363,690. Equity in the 2020 report amounted to DKK 418,926.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202001/01/2020 – 31/12/2020 | -736K | -1.4M | 741K | 419K | 2 |
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringNo. Betamab ApS is registered in the Danish CVR register with the status Dissolved and ceased on 17 May 2022.
The CVR number of Betamab ApS is 40337326.
In 2020, Betamab ApS reported a gross profit of DKK -736,481.
Betamab ApS had 2 employees in 2020 according to the Danish CVR register.
Betamab ApS was founded on 11 March 2019.
Betamab ApS was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi (industry code 721100).
As of May 17, 2022, 18. juni 2024 P/S has stepped down as auditor of Betamab ApS.
As of May 17, 2022, Preben Meldgaard has stepped down as liquidator of Betamab ApS.
On May 17, 2022, Betamab ApS exited liquidation.
Betamab ApS was dissolved on May 17, 2022.
As of October 5, 2021, Søren Mouritsen has left the board of directors of Betamab ApS.
As of October 5, 2021, Morten Peter Meldal has left the board of directors of Betamab ApS.
As of October 5, 2021, Preben Meldgaard is registered as liquidator of Betamab ApS.
As of October 5, 2021, Søren Mouritsen has stepped down as adm. dir. of Betamab ApS.
As of October 5, 2021, Teit Eliot Johansen has stepped down as chairman of Betamab ApS.
As of October 5, 2021, Morten Peter Meldal has stepped down as director of Betamab ApS.
On October 5, 2021, Betamab ApS entered liquidation.
Betamab ApS has published its annual report for 2020. Gross profit came to DKK -736,481, and the net result was DKK -1,363,690.
Betamab ApS has published its interim report for the period March 11, 2019 to December 31, 2019.
As of June 30, 2020, 18. juni 2024 P/S has been appointed auditor of Betamab ApS.
As of March 31, 2020, Søren Mouritsen has joined the board of directors of Betamab ApS.
As of March 31, 2020, Morten Peter Meldal has joined the board of directors of Betamab ApS.
As of March 31, 2020, Teit Eliot Johansen is registered as chairman of Betamab ApS.
As of March 11, 2019, Søren Mouritsen is registered as adm. dir. of Betamab ApS.
As of March 11, 2019, Morten Peter Meldal is registered as director of Betamab ApS.
Betamab ApS was founded on March 11, 2019.
